CO2 GRO’s Sam Kanes on building revenue growth through flowers.

“We started 6 years ago in algae, hydroponic lettuce, hydroponic peppers at University of Guelph. Our journey was never cannabis to begin with. Cannabis showed up all hot and bothered last year. Now it is under some stress because people are realizing growers will ultimately have excess capacity and we are efficiency improvement for them to maintain margins as they shrink…” States Sam Kanes, VP of Business Development and Director at CO2 GRO Inc. (TSXV: GROW), in an interview with InvestorIntel Corp. CEO Tracy Weslosky.

Tracy Weslosky: Let us start by congratulating you. News just out, your Michigan Flower grow trials have just come in. Can you talk to us a little bit about this?

Sam Kanes: Sure. It has been going on for 3 months now. We have had 5 trials do date. All of them show outstanding acceleration of growth and therefore value to future customers of ours. They came in Michigan, the Kalamazoo area. That is the number 3 growing area in the U.S. in terms of greenhouses. A lot of those are flowers. Our first U.S. representative that is with us now full-time as of this week, courtesy of raising some money, is in Kalamazoo. He is going to start there, work his way through Michigan, Ohio and the U.S. Midwest making commercial revenue for us in flowers.

Tracy Weslosky: I will tell you, we love your trading symbol, GROW, G-R-O-W. Can you dumb this down for us a little bit, I had previously understood that say you have 4 crops of cannabis in a greenhouse that you would then have 5 by utilizing the CO2 GRO patented technology. Let us start there. Can you correct me and help our viewers understand GROW better?

Sam Kanes: Cannot correct you because you are accurate. You are also accurate, by the way, the flowers. If you have a 3 month month cycle, we can make that 2 months. You add additional crops in the world of flowers as well as anything else that you want to mature faster than you are otherwise doing. Lettuce we have said now is probably 2 extra crops in California with confidence. They grow 4. We believe we can grow 6 because they are 99% leaves and leaves are what we grow the best and the fastest with our technology. 

Tracy Weslosky: You really had a lot of foresight to get into this particular sector because you can take advantage of the cannabis sector and agribusiness. Is that correct?

Sam Kanes: No. We started 6 years ago in algae, hydroponic lettuce, hydroponic peppers at University of Guelph. Our journey was never cannabis to begin with. Cannabis showed up all hot and bothered last year. Now it is under some stress because people are realizing growers will ultimately have excess capacity and we are efficiency improvement for them to maintain margins as they shrink on a go forward basis down towards other growers of other commodities like flowers and corn and cotton. 

Tracy Weslosky: Sam I understand that CO2 GRO’s most competitive advantage, the key word here is greenhouses. Is that correct?

Sam Kanes: That is not quite correct. Greenhouses come in all shapes and sizes. Some that use CO2 gas will help a little bit in terms of their incremental value. They are averaging about 33% more yield when they add CO2 gas in their greenhouses, but most greenhouses worldwide are porous or in fact open air, like California’s, which we visited a month ago. There you have a million square foot greenhouse, it has not wall. It has not glass. It has no structure.  It is wide open. You cannot use CO2 gas in there…to access the complete interview, click here

Disclaimer: CO2 GRO Inc. is an advertorial member of InvestorIntel Corp.




Move over Fantasy Football, the Cannabis Market just got very real.

Forget the Fall sport season because if you haven’t been watching the Cannabis Breakfast Club, we have some awe-inspiring numbers that may get you on-side and looking at stock charts with your morning coffee. Yesterday, we published To be a Billionaire or not? The Canadian Cannabis Breakfast Club struggles with U.S. border entry concerns where we address the significant challenges arising from border crossing concerns for Canadian executives and investors alike entering the U.S.

Speaking of entry am I the only suffering from the colossal cannabis market envy and interested in whether there is room to still enjoy what appears to be a bud bull market?

While Terry Booth of Aurora Cannabis Inc. (TSX: ACB | OTCQB: ACBFF) had been a client in 2015, I recall attending meetings for financings and listening as bankers would explain why they were not interested in cannabis…. this column is dedicated to all of us that could have, should have but maybe didn’t… and more importantly is it too late?

Wince forward.

If we had bought $100k in Aurora Cannabis stock on January 2, 2015 at $0.40, as of market close last night at $10.87, our stock would be worth $2,717,500.

Taking one more step backwards into the past, imagine that we had invested this same fantasy $100k in the 4 leaders in the Canadian Cannabis Breakfast Club in 2015…. what may we have been worth this morning?

Let’s break it down.

Hypothetically, we would have bought 12,195 shares of Canopy Growth Corporation (TSX: WEED) at $2.05, which closed at $63.40 today, market cap $14.5B – and acquired 62,500 shares of Aurora Cannabis Inc. (TSX: ACB) at $0.40, they closed at $10.87 today, market cap $10.35B. Then perhaps we would have selected 23,810 shares of Aphria Inc. (TSX: APH) at $1.05, they closed at $19.28 today, market cap $4.48B. And finally, scoring 31,646 shares of Cronos Group Inc. (TSX: CRON) at $0.79, they closed at $16.25 – market cap $2.87B. And voila, our fantasy 100k would be today worth nearly $2.5M this morning ($2,426,574.00) — a stunning 2326.57% lift in 33 months!

Wow.

Now where are we today? I ask an the CEO of CannaIncome Fund Arthur Kwan – is it too late? He responds: “With Tilray (NASDAQ: TLRY) reaching an intra-day high of US$300 and closing at US$214 today, the mass hysteria surrounding cannabis stocks continues. With a market capitalization of US$20 billion, it is hard to fathom that Tilray, in a matter of a few short months since going public, is now larger than Canopy Growth (TSX: WEED) and other well-known brands, including WhirlPool, Harley-Davidson, and Hyatt Hotels.

While there is no doubt that this is a very over-heated market, we continue to believe that there’s value in this sector, although now you may have to dig a little harder to find that hidden gem. We see opportunities in the next ‘wave’ of growth companies as we get closer to legalization in Canada including edibles, beverages, and biosynthesis.”

He tells me that CannaIncome is maintaining their market advantage by “investing in the early pre-IPO rounds at significant discounts to public company valuations.”

InvestorIntel Editor Matthew Bohlsen provided us with the following updates on half a dozen cannabis sector companies that are advertisers on InvestorIntel. The companies are listed by market cap, these numbers were taken from TD Waterhouse on September 20, 2018.

WeedMD Inc. (TSXV: WMD), $228.04M Market Cap: WeedMD Inc. is a Canadian licensed producer and distributor of cannabis with large production facilities in Canada. The Company recently announced it has completed the export of its cannabis genetics to Australia’s Medifarm.

Edward Harris, Managing Director of Medifarm, said: “Medifarm prides itself on the cultivation of exclusive cannabis genetics, supported by proven breeding programs used in university and hospital clinical trials for therapeutic use. WeedMD’s highly regarded cannabis strains will help us bring Australians continued access to a diverse set of consistent, quality cannabis products, ensuring that our patients have access to clinically validated and cost-effective medicine for their therapeutic use is paramount for Medifarm.”

Early in September 2018, WeedMD announced it has now completed the first harvest from its modern greenhouse in Strathroy, Ontario. The Company marked the event with a WeedMD “First Harvest” celebration party, a community open house that welcomed well over 120 guests that included WeedMD’s Board of Directors, local government, business leaders, investors, media representatives and employees.

Keith Merker, CEO of WeedMD said: “We’re proud to have been able to share this important milestone with our community, stakeholders, employees and industry. The first harvest was completed in early September and resulted in an impressive yield from our first 10,000 square foot grow room.”

I am guessing it must have been a great party, and I hope to get an invitation to the next one as this WeedMD is having great success both in Canada and soon in Australia.

Scythian Biosciences Corp. (CSE: SCYB | OTC – Nasdaq Intl: SCCYF), $173.9M Market Cap: Scythian Biosciences Corp. is an international cannabis company with a focus on the burgeoning U.S. medical cannabis marketplace. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami. It is this comprehensive approach that is positioning Scythian as a future frontrunner in the United States’ medical cannabis industry.

Scythian has initiated its international expansion by launching additional cannabis related activities across the globe. The Company is evaluating several strategic initiatives and pursuing partnerships with local cultivators, pharmaceutical import and distribution entities and universities in North America, South America, Caribbean and beyond.

Just as any area of the body begins to swell after impact and injury due to inflammation, brain tissue itself does as well. Unfortunately, because the brain is confined inside the skull, the inflammation naturally triggered ends up causing even more damage as the process continually pushes already-injured brain tissue against bone. For contact sports players, repeated concussions can have devastating effects later in life. Cannabinoids are an effective treatment for mild brain trauma (concussions). This is going to be great news for professional sports organizations involved in contact sports and should hopefully lead to wide spread adoption for Scythian’s therapy and products.

Viridium Pacific Group Ltd. (TSXV: VIR), $44.82M Market Cap: Viridium Pacific Group Ltd. is a Canadian producer of medical cannabis products. It is proceeding to meet the health Canada requirements to amend its current producer license to include a license to sell. The Company is involved in consumer wellness and biotech innovation, with interests spanning across agricultural production, property development, and financial services.

Viridium Pacific is positioned to develop and expand into new markets across multiple platforms. Earlier this year, a subsidiary of Viridium, Experion Bio-technologies acquired 25 new cannabis strains from a renowned Dutch supplier, increasing the number of strains available from 2 to 27. The new cannabis strains acquired by Experion are proprietary strains developed in one of the most sophisticated breeding programs in the world.

Viridium has signed a Letter of Intent (September 13, 2018) with Montreal Medical Cannabis Inc. (“MMCI”) to establish a partnership in Pointe Claire, Quebec. With only 9 of 116 Canadian license producers headquartered in the province, Quebec represents a significant opportunity for Viridium to establish licensed cannabis cultivation and distribution. Viridium Pacific will provide expertise to help prepare the MMCI facility for Health Canada inspections, and expedite the application process under its licensed subsidiary, Experion Biotechnologies Inc. The facility currently under renovation is 76,000 square feet with an anticipated output of cannabis over 10,000 kg per year. On October 17, 2018, Canada is to become the third nation in the world to formally legalize cannabis for recreational use and become the first G7 nation to do so. Viridium are in a perfect position in a fast-growing industry with new legislation ready to take effect.

NanoSphere Health Sciences Inc. (CSE: NSHS) Market Cap $37.66M: NanoSphere Health Sciences Inc.’s Evolve Formulas product is the provider of the world’s first and only scientifically proven nano particle delivery system for cannabis. For those that can remember the original Star Trek series, the Evolve product administers directly into the system in a similar way to the Doctor on the Enterprise administered medicine. They called it a hypo-spray. This cutting edge technology eliminates the need for inhalation or ingestion of cannabis, offering users a safer and more effective method of consumption.

The onset time of cannabinoids delivered by the NanoSphere Delivery System™ is just 10 minutes, thereby relieving the user from pain and anxiety in an extremely short period of time. NanoSphere was recognized as Company of the Year for Nano Biotechnology and Innovative, Company of the Year for Healthcare, and three 2018 Global Awards from ACQ5, a premier global corporate magazine. NanoSphere has partnered with Delta 9 Cannabis INC to bring products from its cannabis brand, Evolve Formulas, into the Canadian market, under an agreement, that will see a 50/50 net revenue share from sale of Evolve Formulas products.

The NanoSphere Delivery System could be an ideal way to deliver vitamins, minerals, super-nutrients into the system as well as eliminate the use for needles to deliver medicines. That’s got to make parents and kids very happy.

Global Cannabis Applications Corp. (CSE: APP | OTCQB: FUAPF), $20.22M Market Cap: Global Cannabis Applications Corp.  (“GCAC”) goal is to build a technology-enabled community to improve the health and wellness of medical patients and users alike. The Company has created the Citizen Green Community, a database that uses a mobile app platform for subscribers to interact with other medicinal cannabis users to share benefits, knowledge and personal experiences from their use.

Their Prescriptii app is designed to help patients find the appropriate products for their medical condition. It allows patients to easily rate the cannabis products they have been prescribed, learn about products that have helped other patients, and provide feedback about the effectiveness.

The Company’s CannaLife app was designed to create conversation, share ideas, and promote education on a single social platform (the Cannabis Facebook?). Real conversations will take place showing users what is trending, who to follow, tag, subscribe, and communities to join. Users can also lead the conversation by creating their own communities or sharing information by taking a snapshot from a web page.

With the Prescriptii and CannaLife apps, and the Citizen Green data platform, GCAC is establishing a leadership position by using science and advance technology to gain important insight into the medical cannabis industry. Because of legislation, data on cannabis use and its effects hasn’t really existed for obvious reasons (who wanted it known that you were a user). Now GCAC is giving medicinal users the chance to record and share experiences on the Company’s Citizen Green apps.

CO2 GRO Inc. (TSXV: GROW), $10.62M Market Cap: CO2 GRO Inc.’s (“GROW”) mission is to accelerate all outdoor and indoor plants naturally, safe and economically using its patented advanced CO2 foliar spray technologies. Recent trials are proof of this, with results on CO2 foliar spray versus CO2 gassing. Spraying dissolved CO2 to the top as well as the bottom of a lettuce leaf is more effective in stimulating dramatically faster plant growth and plant size/mass than CO2 gassing. This also proves why GROW’s CO2 Foliar Spray technology integrated into advanced irrigation boom trials are showing sharply faster and larger plant growth.

CEO John Archibald noted: “This additional St. Cloud State University discovery and success integrating our CO2 technology into irrigation spray booms provides further evidence of the commercial potential of our technology. Our revenue generation model is long term site technology licenses and lease of our integration equipment in both indoor and outdoor boom spray systems.”

In August, CO2 GRO conducted their second cannabis trial with a positive commercial indoor trial. The second trial was on a leafier indicia strain that yielded an estimated 60% increase in bud value whereas the first trial on a stringier sativa strain yielded an estimated 45% increase. CO2 GRO’s Indica cannabis trial bud weight increased 20%, was grown 20% faster and had 75% more THC than the control bud group.

It is kind of amazing when you think how this could possibly solve food shortage problems and create a stronger cannabis strain. More food is going to be needed globally each year, and CO2 GRO can play an important role.




CO2 GRO’s John Archibald on Revolutionizing the Cannabis Market through Technology

“It is based on the fact that we grow it more quickly and we are getting a higher bud grade. When you take those two things together we are getting 45%. To add to that the THC levels have increased as well. We did not include that in that 45%. In our second set of results we actually increased it to 60% and we did include the fact that we had increased the THC levels for total bud value.” States John Archibald, CEO and Director of CO2 GRO Inc. (TSXV: GROW), in an interview with InvestorIntel Corp. CEO Tracy Weslosky.

Tracy Weslosky: John, so happy you could join us because I thought this headline was substantial, CO2 GRO Revolutionizing Cannabis with a 45% Bud Value Increase. Okay, is it just me or is that not phenomenal? 

John Archibald: That is very, very, very good. It is based on the fact that we grow it more quickly and we are getting a higher bud grade. When you take those two things together we are getting 45%. To add to that the THC levels have increased as well. We did not include that in that 45%. In our second set of results we actually increased it to 60% and we did include the fact that we had increased the THC levels for total bud value.

Tracy Weslosky: For everybody out there in InvestorIntel that is interested in the cannabis market and they are looking for ways to get involved, but maybe not quite directly due to the challenges with legalization, and there is a lot of confusion in this market. CO2 GRO, if I dumb this down a little bit, is actually a technology that can be utilized in any agribusiness opportunity. Is that correct? 

John Archibald: Certainly. Basically it is the foliar spray of water that is saturated with CO2. What happens is that the CO2 goes onto the leaf and the leaf cuticle is a semi permeable membrane and the CO2 will go into the leaf and it causes it to grow more quickly. In essence that is what happens. It is a very, very simple process that can be integrated into almost everybody’s irrigation systems. 

Tracy Weslosky: Of course, in the cannabis market we have a race with all these companies trying to attract everybody’s investment dollars. They must be lined up at your door because if I understand correctly, is this correct, instead of maybe having 4 crops a year they can have 5? It is that significant. Is that what we are talking about?

John Archibald: They could have an extra crop per year, yes. We are certainly talking to a lot of big LPs right now about doing trials with them. 

Tracy Weslosky: What about your patent? I think we discussed this last time. Can you give me an update on this process? 

John Archibald: Certainly. We had filed a provisional patent. We had filed the provisional patent and then done all the research work to back up our claims. We have done all that work in the past 12 months. Now the patents have been totally submitted and are pending. They have gone from a provisional status to a patent pending status. 

Tracy Weslosky: CO2 GRO, which is GROW on the TSX Venture, last month you were up like 45%. What should we as shareholders anticipate this next month because this news has just come out in the last week? 

John Archibald: I think we are going to see the share price keep going up. As we start doing some real work with the LPs I think you will see that the share price surge ahead again…to access the complete interview, click here

Disclaimer: CO2 GRO Inc. is an advertorial member of InvestorIntel Corp.




CO2 GRO revolutionizing cannabis with a 45% bud value increase

CO2 GRO Inc. (TSXV: GROW) (“GROW”) is a Canadian company based in Toronto, Ontario just announced a 45% increased commercial cannabis bud value growth in trials yesterday. Using their CO2 technologies they are dedicated to increasing the growth of all indoor and outdoor value plants by increasing their clients’ plant yields in a safe, sustainable and economic way. Their CO2 technologies are developed, proven and scalable. GROW are continuing to perform CO2 foliar spray grow trials for cannabis, lettuce, micro greens, flowers and peppers in various growing conditions, using their novel PCT patent pending CO2 Foliar Spray Technology.

CO2 GRO’s mission

The technology works by transferring CO2 gas into water and foliar spraying for use across the entire plant leaf surface area, which is a semi permeable membrane. The dissolved concentrated CO2 then penetrates the leaf’s surface area naturally like concentrated nicotine dissolves through human skin into the bloodstream from a nicotine patch.

GROW has engaged St. Cloud State University research team to evaluate the veracity of its  technology. Initial experimentation was designed to identify the impacts of long term (germination to harvest) exposure to CO2 enriched foliar spray. Results of this initial experiment showed a 4 fold chlorophyll sustained increase. Notable in these initial experiments is the rapidity of physiological response seen in CO2 exposed plants. This data is encouraging and consistent with the hypothesis of significant growth enhancement with CO2 delivery via foliar spray.

Trial verses control test

GROW also has a number of outdoor Canadian cannabis and hemp growth trials pending as well as indoor trials with large cannabis licensed producers (LPs). GROW has six ACMPRs cannabis growth trials underway, with recent results (announced July 25, 2018) showing a 45% increase in cannabis bud value using GROW’s patented spray technology.

John Archibald, CEO and Director of CO2 GRO states: “The whole idea of the patent is it is very unique. It is the only patent in the world that we can find that talks about the spraying of CO2 infused water onto plants. The test results that we are getting now prove it out. We are doing micro-green trials as well. Those are a little shorter than the cannabis trials. There is a variety of companies out there that have gotten into this space both in North America and Europe and it is a huge opportunity for us because we give them that additional growth with the CO2 foliar spray”.

GROW’s global target plant markets are retail food (at $8 trillion per year), retail non-food plants (at an estimated $1 trillion per year), and legal retail cannabis that may reach $50 billion per year by 2022. GROW’s sole focus is working with its plant grower and agri-industrial partners in proving and adopting its CO2 technologies for specific growers’ plant yield needs.

The growing global population and climate change could create food shortages and a heavy demand on fresh food and water supply to feed the planet. The investment opportunity is enormous when one considers the size of the potential market. This is great news for CO2 GRO Inc.




CO2GRO’s CEO on the only patent in the world that sprays CO2 infused water onto plants

April 18, 2018 – “The whole idea of the patent is that it is very unique. It is the only patent in the world that we can find that talks about the spraying of CO2 infused water onto plants. The test results that we are getting now prove it out.” states John Archibald, CEO and Director of CO2GRO Inc. (TSXV: GROW), in an interview with InvestorIntel’s Andy Gaudry.

Andy Gaudry: There has been a lot of exciting things happening for you recently. You guys were recently named a top 50 company by the TSXV. How has that added exposure helped the company? 

John Archibald: It has helped us. It, sort of, underscores our strategies and growth models as seen by the shareholders and investors.

Andy Gaudry: That is fantastic. I know last time when you were in Mr. Kanes mentioned you guys were on target for revenue by Q3 of this year. Are you guys still on target for that? 

John Archibald: We certainly are. We are definitely on for Q3. We are actually hoping to sneak a little bit into Q2. We are advancing that rapidly with our growth trials. 

Andy Gaudry: Onto your growth trials in your recent corporate announcement, how are the growth trials coming?

John Archibald: They are going very well. We have got 4 legal ACMPR cannabis growth trials. We have got some microgreens growth trials and we are having those backed up by a research at a major U.S. AG university. They are going very well. We are seeing excellent results. 

Andy Gaudry: Can you touch a little bit more about the results that you are dealing with? 

John Archibald: We are visually seeing very good results within the cannabis, but we have yet to do an analysis. We will not have those results for about another 6 to 8 weeks. 

Andy Gaudry: In addition to your cannabis growth trials, can you tell us a bit more about your microgreen trials? 

John Archibald: Yes. We are doing microgreen trials as well. Those are a little shorter that then cannabis trials. Typically microgreens grow from about 10 days to about 30 days. We are doing various trials there. Looking at starting with no nutrients, no additional nutrients and then balancing nutrients with the addition of the CO2 foliar spray. We have already got very good measureable results and we are expecting to improve those. 

Andy Gaudry: Can you touch on about your urban agriculture initiatives? 

John Archibald: Yes. Urban agriculture, sort of, ties in with our microgreens. They are grown within a 40-foot container. They are hyper grown. It is a controlled atmosphere and they are stacked in the container. They get 5 to 10 times the amount of growth that you normally would get in an outdoor situation. It is becoming increasingly popular. There is a variety of companies out there that have gotten into this space both in North America and Europe and it is a huge opportunity for us because we give them that additional grow with the CO2 foliar spray. 

Andy Gaudry:  Can you please expand on your CO2 foliar spray patent?   

John Archibald: I can. We wrote that patent last July. The trials that we are doing right now are proof of the patent itself. The whole idea of the patent is that it is very unique. It is the only patent in the world that we can find that talks about the spraying of CO2 infused water onto plants. The test results that we are getting now prove it out…to access the complete interview, click here

Disclaimer: CO2GRO Inc. is an advertorial member of InvestorIntel Corp.